Back | Next |
home / stock / nbix / nbix message board
Subject | By | Source | When |
---|---|---|---|
I predict $NBIX will be $117.43 (or more) | Kagami | investorshub | 11/10/2017 5:45:48 AM |
Hi guys! Any forecasts on price targets? I'm contemplating | jtf3 | investorshub | 11/03/2017 8:47:06 PM |
$NBIX buy 50.20 | stocktrademan | investorshub | 07/27/2017 3:14:25 PM |
$NBIX bullish 52.71 | stocktrademan | investorshub | 05/11/2017 4:40:41 PM |
Nice win here!! Great news, should continue higher | rightothesky | investorshub | 04/12/2017 1:45:51 PM |
$52.28 NHOD!! | TheFinalCD | investorshub | 04/12/2017 1:12:47 PM |
Ya, that big buy at $49 was a | rightothesky | investorshub | 04/12/2017 12:04:21 PM |
HIT $51.99 SO FAR | TheFinalCD | investorshub | 04/12/2017 11:25:10 AM |
Wow. Sure is! | rightothesky | investorshub | 04/11/2017 10:12:22 PM |
9300 TRADE @ $49 | TheFinalCD | investorshub | 04/11/2017 10:08:01 PM |
Anyone wanna throw some predictions out there? | rightothesky | investorshub | 04/11/2017 10:04:35 PM |
FDA Approval........ | TheFinalCD | investorshub | 04/11/2017 10:02:55 PM |
Neurocrine Announces FDA Approval of INGREZZA (valbenazine) Capsules | TheFinalCD | investorshub | 04/11/2017 9:44:14 PM |
nice upside | gregque | investorshub | 04/11/2017 9:40:08 PM |
Ah movement on news | Awl416 | investorshub | 04/11/2017 9:30:20 PM |
This 10yr DCF implies Neurocrine Biosciences $NBIX is | ValueInvestor15 | investorshub | 02/14/2017 1:33:11 PM |
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are trading | AnthonyJackson | investorshub | 01/18/2017 2:41:39 PM |
AnthonyJackson6: Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are trading lower by over 5% a | AnthonyJackson6 | investorshangout | 01/18/2017 2:36:05 PM |
Hattlem: $NBIX immediate resistance @ the 10 DMA but still looks like it wants higher on the daily | Hattlem | investorshangout | 02/15/2016 2:04:24 PM |
Lucky Jimmy: Right on, I will be watching for them ty. | Lucky Jimmy | investorshangout | 01/22/2016 3:56:06 PM |
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
NASDAQ Market:
Neurocrine Biosciences Inc. Website:
Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024 PR Newswire CAHtalyst™ Pediatric ...
Neurocrine Biosciences Supports Tardive Dyskinesia Awareness Week by Advocating for Routine Screening and Monitoring PR Newswire Approximately 600,000 people in the United States live with tardive dyskinesia (TD), and about 65% have not yet been diagnosed 1-3 The d...
Neurocrine Biosciences Presented CAHtalyst™ Pediatric Study Baseline Characteristics and CAHtalog™ Registry Data at PES 2024 PR Newswire CAHtalyst™ Pediatric Study Baseline Characteristics Data Highlight Need for Novel Treatments in Children and Adolesce...